ArticleInternal medicine (Tokyo, Japan)2022
Combined Therapy with Ixazomib, Lenalidomide, and Dexamethasone for Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome.
Tomoki Suichi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.